51 lines
3.6 KiB
JSON
51 lines
3.6 KiB
JSON
{
|
|
"date": "2026-04-15",
|
|
"llm_provider": "google",
|
|
"recommendations": [
|
|
{
|
|
"ticker": "ACHC",
|
|
"rank": 1,
|
|
"company_name": "Acadia Healthcare Company, Inc.",
|
|
"description": "Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico.",
|
|
"strategy_match": "short_squeeze",
|
|
"pipeline": "short_squeeze",
|
|
"final_score": 85,
|
|
"confidence": 8,
|
|
"risk_level": "moderate",
|
|
"reason": "This is a prime short squeeze setup featuring an extreme 42.1% short interest and 6.5 days to cover, a strategy boasting a historical 60.0% 7-day win rate. The stock is exhibiting momentum acceleration, breaking into a strong uptrend well above its 50-day SMA of $21.24 with rising on-balance volume. Options market sentiment strongly corroborates the technical breakout, marked by an unusually low 0.31 put/call volume ratio indicating heavy call accumulation. The primary risk is a broader market selloff or premature profit-taking ahead of their upcoming April 29th earnings report.",
|
|
"entry_price": 26.610000610351562,
|
|
"discovery_date": "2026-04-15",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "ANAB",
|
|
"rank": 2,
|
|
"company_name": "AnaptysBio, Inc.",
|
|
"description": "AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.",
|
|
"strategy_match": "short_squeeze",
|
|
"pipeline": "short_squeeze",
|
|
"final_score": 82,
|
|
"confidence": 8,
|
|
"risk_level": "high",
|
|
"reason": "This setup combines a high squeeze potential (30.6% short interest, 9.8 days to cover) with a hard, impending catalyst: the April 20 spin-off of First Tracks Biotherapeutics. With the corporate action just 5 days away, shorts are heavily incentivized to cover to avoid corporate action liabilities, supported by a fresh MACD bullish crossover with a positive 0.816 histogram. The options flow further corroborates the bullish setup with a low 0.41 put/call volume ratio against a strong technical uptrend. However, the thesis carries risk due to recent insider selling of approximately $2.2M by the CEO and Director, alongside a high ATR of 6.0% demanding careful position sizing.",
|
|
"entry_price": 67.88999938964844,
|
|
"discovery_date": "2026-04-15",
|
|
"status": "open"
|
|
},
|
|
{
|
|
"ticker": "EQR",
|
|
"rank": 3,
|
|
"company_name": "Equity Residential",
|
|
"description": "Equity Residential owns and manages 312 rental properties consisting of 85,190 apartment units primarily in major U.S. coastal and high-growth metro areas.",
|
|
"strategy_match": "volume_divergence",
|
|
"pipeline": "volume_divergence",
|
|
"final_score": 75,
|
|
"confidence": 7,
|
|
"risk_level": "low",
|
|
"reason": "The stock presents a robust quantitative volume divergence signal, with OBV running +22.1% above average volume while the price remained flat (+1.8%), indicating covert multi-week institutional accumulation. Technical indicators are aligning favorably right now, characterized by a fresh MACD bullish crossover and the price holding firmly above its 20-day EMA and VWAP. Unusually high volume on deep ITM options, specifically 751 volume on $50 strike calls against an OI of just 2, alongside a low volatility profile (ATR 1.9%) offers an attractive low-risk entry. As a REIT, the primary risk is macroeconomic interest rate sensitivity which could unexpectedly compress valuation multiples despite the technical breakout.",
|
|
"entry_price": 61.290000915527344,
|
|
"discovery_date": "2026-04-15",
|
|
"status": "open"
|
|
}
|
|
]
|
|
} |